Zhai, Y., Li, X., Li, Y., Zheng, J., Dai, X., Li, X., Zhu, Y., Guan, K., Wahafu, W., Wang, X., Song, Y., Hu, L., Hu, Z., Zhang, S., Ye, X. (2026). Cadonilimab plus lenvatinib in advanced renal cell carcinoma: Interim analysis of a prospective, multi-cohort phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.501